Ivermectin’s Accidental Breakthrough: A Lifeline for Parkinson’s and Alzheimer’s Sufferers

Right now. we do not know why iy works.  We do not need to know and can wait a thousand years fr the science.  What matters is that it works.

We can also infer that an early therapy for any cancer needs to be a course in Ivetrmectin.

Recall we have actually nothing to help either Parkinsons or Alzheimers to hand.  So why the underground fight surely funded by Big Pyarma?

Does it not occur to anyone that our civilization needs to be healthy?

Ivermectin’s Accidental Breakthrough: A Lifeline for Parkinson’s and Alzheimer’s Sufferers

https://choiceclips.whatfinger.com/2025/10/11/ivermectins-accidental-breakthrough-a-lifeline-for-parkinsons-and-alzheimers-sufferers/

Article with excellent info is below this top clip by Dr. Makis 🛑Dr. William Makis is reporting unprecedented success using ivermectin for two of our most devastating neurological conditions: Parkinson’s and Alzheimer’s disease.

A stunning revelation from the front lines of medicine. Dr. William Makis is reporting unprecedented success using ivermectin for two of our most devastating neurological conditions: Parkinson’s and Alzheimer’s disease. His accidental discovery is yielding results that defy conventional expectations. For Parkinson’s, high-dose ivermectin (60-72mg) is facilitating remarkable recoveries. Patients on maximum standard treatments, once barely mobile, are now experiencing dramatic improvements in movement and symptoms. One such patient, after a few weeks of treatment, returned to playing golf—an activity lost for years. The outcomes in Alzheimer’s are even more profound.

Dr. Makis details how family members, following his protocol of low-dose ivermectin (12-24mg for a few days), are witnessing what can only be described as medical miracles. Loved ones who had not recognized family members for years are suddenly reconnecting. Memories are flooding back; cognitive abilities are being restored. In one extraordinary case, a patient was taken off hospice after their condition improved so drastically. The stories are heart-rending: “My grandma’s back.” Families are reclaiming precious time with loved ones they felt they had lost forever. All from a few pills of a medication with a well-established safety profile.

Dr. Makis challenges the medical establishment, noting that supportive preclinical research on ivermectin and Alzheimer’s appears to have been scrubbed from mainstream search engines, a silent testament to the battle over this repurposed drug. He urges the public to look at the evidence he shares on his platforms. The potential for a safe, accessible, and effective treatment for these neurodegenerative scourges is too significant to ignore. The question remains: When the evidence is this compelling, and the reward is the reversal of human suffering, why isn’t this being researched at the highest levels?

Ivermectin’s Accidental Breakthrough: A Lifeline for Parkinson’s and Alzheimer’s Sufferers

In a compelling video shared above on October 10, 2025, Dr. William Makis, a prominent cancer researcher and advocate for repurposed drugs, revealed stunning anecdotal successes using Ivermectin to treat Parkinson’s and Alzheimer’s diseases. The post, which has garnered over 320,000 views, highlights what Makis describes as an “accidental discovery” that is yielding “medical miracles” for patients long thought to be beyond help. Drawing from Makis’ extensive clinical observations and his platform @MakisMedicine

, this revelation underscores Ivermectin’s potential beyond its established role as an anti-parasitic medication.

As conservatives have long championed Ivermectin for its safety and efficacy during the COVID-19 era, this new application could revolutionize treatment for neurodegenerative conditions, offering hope where traditional medicine has fallen short. The story begins with an unintended finding in preclinical research. Makis explains that the link to Parkinson’s stemmed from a mouse model of parkinsonism, where Ivermectin showed promising effects on neurological symptoms. For Alzheimer’s, he points to a preclinical study concluding that Ivermectin has a positive impact and warrants further investigation.

Alarmingly, Makis notes that this study has been “scrubbed” from Google searches, only accessible via alternative engines like DuckDuckGo. This suppression, he argues, is part of a broader battle over repurposed drugs like Ivermectin, which lack patent protection and thus big pharma profits. Conservatives have echoed these concerns, viewing such censorship as evidence of establishment bias against affordable treatments.Makis, who boasts the world’s largest Ivermectin clientele primarily for cancer, stumbled upon these benefits when patients inquired about using the drug for elderly relatives with neurodegenerative issues. For Parkinson’s, he recommends high doses—60 to 72mg—tailored to individual tolerance. One striking case involved a patient on maximum standard treatments, barely mobile, who after a few weeks of Ivermectin regained enough function to play golf, an activity abandoned years prior. Makis reports similar reversals in multiple Parkinson’s patients, with improvements in movement and symptoms that defy conventional expectations.

A testimonial from a 78-year-old Nebraska man with eight years of Parkinson’s diagnosis illustrates this: After four months on an escalating regimen of Ivermectin (starting at 1mg/kg/day, increasing to 1.5mg/kg/day) combined with Fenbendazole, he was effectively cured, regaining full mobility and independence. The outcomes for Alzheimer’s are even more profound, often manifesting as emotional reunions. Makis advises low doses—12 to 24mg for a few days—to avoid side effects like confusion in older patients. Families have reported loved ones recognizing relatives after years of disconnection, with memories flooding back and cognitive abilities restoring. In one extraordinary instance, a patient was removed from hospice due to dramatic improvement.

Makis shares heart-wrenching stories: “My grandma’s back,” families exclaim, reclaiming precious time with those they thought lost forever. These results, achieved with just a few pills of a drug with a well-established safety profile, challenge the medical status quo.Makis’ work aligns with emerging research linking neurodegenerative diseases to infections and immune suppression. In a recent podcast appearance with Nicole Shanahan, Stanford’s Dr. Annelise E. Barron discussed unpublished data showing bacterial-viral co-infections in 89% of glioblastoma tumors and associated with Alzheimer’s cognitive decline. These pathogens weaken innate immunity, predisposing individuals to both dementia and cancer. Makis notes that both conditions respond to Ivermectin, attributing its efficacy to anti-inflammatory, anti-viral, and potentially immune-boosting properties.

Dr. William Makis MD shares Ivermectin dosage protocols for cancer: Low dose for remission, medium dose for most cancers, high dose for aggressive types, very high dose for advanced cases.

This connection is particularly relevant amid reports of surging dementia cases post-COVID-19 vaccination, which conservatives attribute to vaccine-induced brain damage. Conservative voices have long touted Ivermectin’s versatility. Discovered from a unique Japanese soil bacteria by Dr. Satoshi Ōmura and Dr. William C. Campbell—Nobel laureates in 2015—the drug’s anti-parasitic prowess extends to anti-inflammatory, anti-viral, and anti-cancer effects. Dubbed a “miracle drug,” it’s saved countless lives in tropical diseases and gained fame during COVID-19 for early treatment protocols championed by figures like Joe Rogan and RFK Jr. Now, its role in neurology could be transformative, especially as Parkinson’s and Alzheimer’s affect millions, with limited effective therapies. Critics dismiss these claims as anecdotal, but Makis urges empirical trials, sharing stories on X and Substack to empower patients.

Big Pharma does NOT want any studies done as Ivermectin is cheap and they cannot make money. Plus they DO NOT want actual studies showing people being cured of a disease that they make a fortune from, billions and billions of dollars per year keeping YOU and loved ones sick. So now Florida steps up… BREAKING: The State of Florida is launching a study on Ivermectin to see if it can potentially cure cancer. This is HUGE.

In Florida, where Makis spoke at events like the World Council for Health Detox and Wellbeing Fair, there’s growing interest in funding research on repurposed drugs like Ivermectin. Florida Surgeon General Dr. Joseph Ladapo has discussed its potential for cancer, signaling a shift toward innovative, accessible treatments. This accidental discovery revives hope for conservatives skeptical of big pharma’s profit-driven model. As Makis challenges, when evidence is compelling and suffering reversible, why isn’t this prioritized? With safe, low-cost Ivermectin, families are witnessing reversals that medicine deemed impossible. As awareness spreads, it could mark the dawn of a new era in neurodegenerative care. Big Pharma and Democrats and their media that make all of the money via Big Pharma companies. can all go to hell. We prefer you live, and they lose their profits and maybe end up in prison for the lies over the decades, killing countless folks so they can have mansions and limos.